Xponance’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,093
| Closed | -$287K | – | 1341 |
|
|
2024
Q1 | $287K | Sell |
8,093
-55
| -0.7% | -$1.95K | ﹤0.01% | 1075 |
|
|
2023
Q4 | $355K | Sell |
8,148
-367
| -4% | -$16K | ﹤0.01% | 1027 |
|
|
2023
Q3 | $325K | Sell |
8,515
-180
| -2% | -$6.87K | ﹤0.01% | 1018 |
|
|
2023
Q2 | $358K | Sell |
8,695
-904
| -9% | -$37.2K | ﹤0.01% | 1002 |
|
|
2023
Q1 | $551K | Sell |
9,599
-32
| -0.3% | -$1.84K | 0.01% | 893 |
|
|
2022
Q4 | $540K | Buy |
9,631
+1,063
| +12% | +$59.6K | 0.01% | 872 |
|
|
2022
Q3 | $363K | Buy |
8,568
+59
| +0.7% | +$2.5K | 0.01% | 948 |
|
|
2022
Q2 | $460K | Buy |
8,509
+548
| +7% | +$29.6K | 0.01% | 882 |
|
|
2022
Q1 | $512K | Sell |
7,961
-184
| -2% | -$11.8K | 0.01% | 886 |
|
|
2021
Q4 | $546K | Buy |
8,145
+4
| +0% | +$268 | 0.01% | 869 |
|
|
2021
Q3 | $557K | Sell |
8,141
-178
| -2% | -$12.2K | 0.01% | 838 |
|
|
2021
Q2 | $568K | Buy |
8,319
+875
| +12% | +$59.7K | 0.01% | 864 |
|
|
2021
Q1 | $514K | Buy |
7,444
+57
| +0.8% | +$3.94K | 0.01% | 767 |
|
|
2020
Q4 | $480K | Sell |
7,387
-51
| -0.7% | -$3.31K | 0.01% | 764 |
|
|
2020
Q3 | $351K | Buy |
7,438
+1,069
| +17% | +$50.4K | 0.01% | 796 |
|
|
2020
Q2 | $299K | Buy |
+6,369
| New | +$299K | 0.01% | 830 |
|